Method of attacking target cells
US11007277B2 · kind B2 · utility
Inventor
Key dates
| Filing date | Aug 12, 2020 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Aug 12, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of killing cells of a targeted cell type in a patient body that utilizes nanoparticles having a first portion, which when exposed to a target portion of a targeted cell type, binds to the target portion and a second portion, joined to the first portion, and comprised of a low resistivity material. The nanoparticles are introduced into a contact area where they contact cells of the targeted cell type. Contemporaneously, the contact area is exposed to a varying magnetic field of insufficient strength to increase the temperature of any part of the patient body by more than ten degrees Celsius, but which creates a current at the nanoparticles sufficient to disrupt function of the targeted cell type.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.